Key Takeaways
- In 2022, 3,582 patent infringement cases were filed in U.S. district courts
- Patent filings dropped 12% from 2021 to 2022 in district courts
- Eastern District of Texas saw 18% of all U.S. patent cases filed in 2022
- In 2022, Eastern District of Texas hosted 642 patent cases (18% national)
- District of Delaware saw 1,028 filings in 2022 (29% of total)
- Northern District of California: 312 cases in 2022 (9%)
- 92% of cases terminated by settlement in district courts 2017-2022
- Plaintiff win rate at trial: 32% in 2022 district courts
- Jury verdicts for patentees: $1.2B total in 2022 (12 trials)
- Median patent litigation cost to trial: $4M for $1-25M at risk 2022
- Total verdict damages 2022: $2.8B across 25 trials
- Reasonable royalty rate median: 3.5% in 2022 awards
- Decline in NPE assertions: 18% YoY in 2022
- Top NPE: IP Edge filed 456 campaigns 2022
- Software patents: 52% of assertions 2022, down from 67% in 2015
U.S. patent lawsuits significantly declined in 2022, with many cases shifting to Delaware.
Case Filings
- In 2022, 3,582 patent infringement cases were filed in U.S. district courts
- Patent filings dropped 12% from 2021 to 2022 in district courts
- Eastern District of Texas saw 18% of all U.S. patent cases filed in 2022
- Total patent cases filed from 2010-2022 averaged 4,200 annually
- NPE filings accounted for 52% of patent cases in 2022
- District of Delaware had 1,028 patent filings in 2022
- Patent cases filed peaked at 6,497 in 2013 post-AIA
- 2023 saw 2,931 new district court patent cases through Q3
- California Northern District filed 312 patent cases in 2022
- From 2017-2022, filings declined 40% overall
- Texas Western District filings rose 25% in 2022 to 245 cases
- ITC patent investigations initiated: 62 in FY2022
- PTAB institution filings: 1,512 IPRs in FY2022
- Federal Circuit patent appeals filed: 1,234 in 2022
- Software patent filings: 1,892 cases in 2022 (52% of total)
- Biotech patent cases: 248 filings in 2022
- 2019 filings: 3,259 district court cases
- NPEs filed 1,862 cases in 2022, down 15% YoY
- Operating company filings: 1,720 in 2022
- Delaware filings: 15% of national total in 2021
- EDTX filings declined 30% post-TC Heartland in 2017
- FY2021 PTAB trials filed: 1,838
- 2020 COVID impact: filings down 20% to 2,949
- Telecom patent cases: 512 filings in 2022
- Medical device patents: 189 cases filed 2022
- Supreme Court patent cert petitions: 142 in 2022
- CAFC original proceedings: 56 patent-related in 2022
- ITC Section 337 filings: 71 in 2021
- PGR filings PTAB: 112 in FY2022
- CBM filings (pre-2021): 385 total cumulative by 2020
Case Filings Interpretation
Damages and Costs
- Median patent litigation cost to trial: $4M for $1-25M at risk 2022
- Total verdict damages 2022: $2.8B across 25 trials
- Reasonable royalty rate median: 3.5% in 2022 awards
- Enhanced damages (treble): awarded in 12% of plaintiff wins 2022
- ITC public interest stays granted: 2% of investigations 2022
- Attorney fees awards to prevailer: $2.1M median 2022
- Cost to interlocutory appeal: $1.5M average 2022
- NPE demand median: $300K pre-suit 2022
- Running royalty post-verdict: imposed in 18% of cases 2022
- Total PTAB costs per IPR: $350K median 2022
- Insurance coverage for patent defense: 45% of companies 2022 survey
- Median verdict $10M-$25M cases: $18.2M 2017-2022
- Lost profits awards: 22% of damages total 2022
- Pre-suit settlement median: $1.2M for tech patents 2022
- Exceptional case fee shifts: 28 under Octane 2022
- ITC bond amounts median: $12M during investigations 2022
- Cost predictability score EDTX: 85/100 2022
- Annual NPE litigation spend: $29B estimated 2022
- Median time to settlement: 18 months district courts 2022
- GAFA defense spend on patents: $5B collective 2022
Damages and Costs Interpretation
Outcomes and Settlements
- 92% of cases terminated by settlement in district courts 2017-2022
- Plaintiff win rate at trial: 32% in 2022 district courts
- Jury verdicts for patentees: $1.2B total in 2022 (12 trials)
- Summary judgment for defendants: 45% of motions granted 2022
- PTAB invalidation rate: 68% of instituted IPR claims cancelled FY2022
- Settlement rate pre-institution PTAB: 35% in FY2022
- District court dismissals: 22% on 12(b)(6) motions 2022
- ITC exclusion orders: 12 issued in FY2022 (19% of completions)
- Federal Circuit affirmance rate: 78% for PTAB decisions 2022
- Patentee trial win rate software cases: 28% 2018-2022
- NPE settlement rate: 90% of cases 2022
- Post-grant review final written decisions: 84% invalidating at least one claim FY2022
- District court trials: 25 patent jury trials in 2022
- Reexamination requests granted: 55% institution rate 2022
- CAFC reversal rate district courts: 22% in 2022
- Willful infringement findings: 15% of trials 2022
- Rule 11 sanctions: 8 imposed in patent cases 2022
- Stipulated dismissals: 65% of terminations 2022
- Bench trials plaintiff win: 41% vs 32% jury 2017-2022
- IPR appeal affirmance: 82% PTAB decisions 2022
- Median damages award at trial: $15.4M in 2022 verdicts
- Average settlement value: $8.2M for NPE cases 2022
Outcomes and Settlements Interpretation
Trends and NPEs
- Decline in NPE assertions: 18% YoY in 2022
- Top NPE: IP Edge filed 456 campaigns 2022
- Software patents: 52% of assertions 2022, down from 67% in 2015
- Post-Alice invalidations: 89% PTAB software patents cancelled 2022
- Big Tech as defendants: 35% of cases 2022
- Repeat players: Top 10 plaintiffs filed 28% of cases 2022
- China-based NPE rise: 15% of filings 2022
- SEP assertions down 22% in 2022
- University patenting litigation: 120 cases 2022, up 10%
- AI patent filings in litigation: 45 cases 2022
- COVID-related patent suits: 89 in 2020-2022
- Venue reform impact: 50% drop EDTX post-Judicial Conference 2022
- Operating co. assertions stable at 48% of filings 2022
- PAE campaigns: 1,234 by top 20 in 2022
- 5G patent disputes: 156 cases 2022
- Biosimilar patent challenges: 210 ANDA Paragraph IV 2022
- Median case pendency district: 24 months 2022
- PTAB institution rate: 62% for IPRs FY2022
- Serial litigation by NPEs: 72% repeat filers 2022
Trends and NPEs Interpretation
Venue and Jurisdiction
- In 2022, Eastern District of Texas hosted 642 patent cases (18% national)
- District of Delaware saw 1,028 filings in 2022 (29% of total)
- Northern District of California: 312 cases in 2022 (9%)
- Western District of Texas: 423 cases in 2022 (12%)
- Post-TC Heartland (2017), EDTX share dropped from 25% to 18%
- Colorado District: 89 cases in 2022, up 40%
- ITC venue used in 62 investigations in FY2022 (2% of filings)
- Delaware median time-to-trial: 2.1 years in 2022
- EDTX median time-to-trial: 1.8 years, fastest venue
- WDTX judge Albright handled 25% of national patent docket in 2022
- NDCA patent cases: 9% national share, stable since 2018
- District of New Jersey: 156 cases 2022 (4%)
- Texas Eastern post-2022 venue reform: filings down 35%
- PTAB as venue: 1,512 petitions filed FY2022
- Federal Circuit jurisdiction over 90% of patent appeals
- Supreme Court took 5 patent cases in 2022 term
- State courts handled <1% of patent cases post-Federal Circuit uniformity
- Waco TX (WDTX): 1,200+ cases pending end-2022
- Marshall TX (EDTX): 400 pending cases 2022
- CDCA: 210 filings 2022 (6%)
- MD Florida: 112 cases 2022
- Illinois Northern: 98 cases 2022
- Georgia Northern: 76 cases 2022
- Nevada District: 45 cases 2022, emerging venue
- 85% of patent cases filed in top 10 venues in 2022
Venue and Jurisdiction Interpretation
Sources & References
- Reference 1UNIFIEDPATENTSunifiedpatents.comVisit source
- Reference 2LEXISNEXISlexisnexis.comVisit source
- Reference 3RPXCORPrpxcorp.comVisit source
- Reference 4USPTOuspto.govVisit source
- Reference 5DOCKETSdockets.justia.comVisit source
- Reference 6PWCpwc.comVisit source
- Reference 7CARDINALcardinal.worksVisit source
- Reference 8USITCusitc.govVisit source
- Reference 9CAFCcafc.uscourts.govVisit source
- Reference 10RPCIrpci.comVisit source
- Reference 11DOCKETALARMdocketalarm.comVisit source
- Reference 12LAW360law360.comVisit source
- Reference 13SCOTUSBLOGscotusblog.comVisit source
- Reference 14FEDCIRfedcir.govVisit source
- Reference 15IAM-MEDIAiam-media.comVisit source
- Reference 16BROOKINGSbrookings.eduVisit source
- Reference 17FDALAWBLOGfdalawblog.netVisit source
- Reference 18USCOURTSuscourts.govVisit source






